Funder
National Natural Science Foundation of China
Reference52 articles.
1. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8;Arch. Ophthalmol.,2001
2. Isorhamnetin reduces glucose level, inflammation, and oxidative stress in high-fat diet/streptozotocin diabetic mice model;Alqudah;Molecules,2023
3. Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions;Cabral de Guimaraes;Br. J. Ophthalmol.,2022
4. Luteolin alleviates epithelial-mesenchymal transformation induced by oxidative injury in ARPE-19 cell via Nrf2 and AKT/GSK-3β pathway;Chen;Oxid. Med. Cell. Longev.,2022
5. Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study;Corazza;BMC Ophthalmol.,2021